Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.
A new CRISPR approach can control genes without cutting DNA, opening a safer path for treating genetic diseases. A newly ...
Crispr Therapeutics, a leader in CRISPR/Cas9 biotechnology, recently received FDA and EMA approval for Casgevy, the first CRISPR/Cas9-based treatment for TDT and SCD. The partnership with Vertex ...
The emergence of advanced genome editing technologies has revolutionized research in life sciences, offering an unprecedented ...
Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) proteins are core components of fast-evolving therapeutic gene editing tools. Scientists have used CRISPR ...
Scientists introduced CRISPR to the world as a gene-editing tool in summer 2012, when landmark papers from two independent groups demonstrated how the system could be wielded to make cuts in DNA. Now, ...
Gene-editing techniques such as CRISPR-Cas9 have many uses in the area of food and agriculture. They can combat persistent drought and disease, and improve the colour and nutritional content of food ...
Im Zuge der Optimierung von Schlüsselverfahren der Genom-Editierung ist es Forscherinnen und Forschern der Abteilung Entwicklungsbiologie / Entwicklungsphysiologie am Centre for Organismal Studies der ...
Scientists have worked tirelessly to develop ever more precise and efficient CRISPR-Cas systems to reach the ultimate goal: safe and effective CRISPR-Cas-based medical treatments. Over the years, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback